Pharmaceutical analysis and characterisation of biomolecules and biosimilars.

Since 1997 A&M STABTEST GmbH is regularly contracted by pharma companies for the pharmaceutical analysis of biomolecules. Since then we were involved in stability studies, release testing and the characterisation of over 30 monoclonal antibodies, more than 20 protein-based pharmaceuticals and five peptides. 1998 we were involved in the stability study of a protein, which in the meanwhile has been granted authorisation as the first biosimilar in the USA. Since then we have been involved in the characterisation, comparative studies and stability testing of five biosimilars proteins.

Over 50 dedicated protein specialists are employed at our site to offer you:


 

Pharmazeutische Analytik und Charakterisierung von Biomolekülen und Biosimilars